07X.F
Annovis Bio, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
1.54
▲ 0.03 (1.85%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.54
Prev close
1.52
Day high
1.54
Day low
1.54
Volume
1.50K
Market cap
$65.78M
P/E (TTM)
—
52W range
1.35 – 4.61
Day trading desk
Gap from prior close
-1.78%
Prior close 1.57
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
1.54 – 1.54
Position in range
—
—
ATR (14D)
0.04
2.72% of price
Prior day high
1.57
PDH
Prior day low
1.57
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 599
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.56%
-0.4%
1M
+0.66%
-2.7%
3M
-20.21%
-22.6%
6M
-26.41%
-38.3%
YTD
-48.26%
-60.2%
1Y
-25.14%
-45.3%
3Y
-86.95%
-161.9%
5Y
-94.88%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 07X.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
2.86M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 20, 26 | HOFFMAN MICHAEL B Director |
BUY | 76.34K | $142.78K | Direct |
| Apr 2, 26 | HOFFMAN MICHAEL B Director |
BUY | 713.80K | $1.50M | Direct |
| Dec 8, 25 | HOFFMAN MICHAEL B Director |
BUY | 45.00K | $193.79K | Direct |
| Nov 24, 25 | HOFFMAN MICHAEL B Director |
BUY | 39.20K | $159.89K | Direct |
| Nov 24, 25 | HOFFMAN MICHAEL B Director |
BUY | 39.20K | $159.89K | Direct |
| Nov 21, 25 | HOFFMAN MICHAEL B Director |
BUY | 20.00K | $69.90K | Direct |
| Nov 14, 25 | HOFFMAN MICHAEL B Director |
BUY | 15.00K | $31.65K | Direct |
| Oct 28, 25 | MACCECCHINI MARIA-LUISA Chief Executive Officer |
BUY | 97.56K | $200.00K | Direct |
| Oct 28, 25 | HOFFMAN MICHAEL B Director |
BUY | 975.61K | $2.00M | Direct |
| Sep 10, 25 | BRUCK CLAUDINE Director |
CONVERSION | 7.14K | $1.00K | Direct |
| Aug 29, 25 | HOFFMAN MICHAEL B Director |
STOCK | 15.00K | $34.35K | Direct |
| Aug 19, 25 | HOFFMAN MICHAEL B Director |
STOCK | 18.64K | $48.28K | Direct |
| Jun 16, 25 | WALSH ANDREW Officer |
STOCK | 500 | $1.45K | Direct |
| Jun 13, 25 | HOFFMAN MICHAEL B Director |
STOCK | 25.00K | $70.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRUCK CLAUDINE |
Director | 13.71K | Conversion of Exercise of derivative security |
HOFFMAN MICHAEL B |
Director | 3.59M | Purchase |
MACCECCHINI MARIA-LUISA |
Chief Executive Officer | 1.21M | Purchase |
MCCARTHY REID S. |
Director | 9.30K | Stock Award(Grant) |
WALSH ANDREW |
Officer | 500 | Stock Award(Grant) |
Fundamentals
Market cap$65.78M
Enterprise value$47.05M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-49.52M
EPS (TTM)$-1.50
Free cash flow$-23.79M
Total cash$18.73M
Total debt$0
Book value / share$-0.09
Shares outstanding42.61M
Float35.32M
Short % of float—
Dividend yield—
Beta (5Y)1.24
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.60
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-703.68%
Return on assets-142.36%
Debt / equity—
Current ratio3.47
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $25.22M | $20.00M | $38.79M | $16.52M | +26.1% |
| Selling, general & admin | $4.48M | $6.70M | $6.24M | $9.00M | -33.1% |
| Total operating expense | $29.70M | $26.69M | $45.04M | $25.51M | +11.2% |
| Operating income | -$29.70M | -$26.69M | -$45.04M | -$25.51M | -11.2% |
| Net interest income | $699.06K | -$1.52M | $667.90K | $182.71K | +146.0% |
| Pre-tax income | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -17.3% |
| Net income | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -17.3% |
| Net income to common | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -17.3% |
| Basic EPS | -1.40 | -2.02 | -6.23 | -3.10 | +30.7% |
| Diluted EPS | -1.40 | -2.31 | -6.23 | -3.10 | +39.4% |
| EBIT | -$29.70M | -$26.69M | -$45.04M | -$25.51M | -11.2% |
| EBITDA | -$29.70M | -$26.69M | -$45.04M | -$25.51M | -11.2% |
| Basic shares | 20.55M | 12.18M | 9.02M | 8.16M | +68.7% |
| Diluted shares | 20.55M | 12.24M | 9.02M | 8.16M | +68.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $19.53M | $10.55M | $5.75M | $28.38M | +85.1% |
| Cash & short-term investments | $19.53M | $10.55M | $5.75M | $28.38M | +85.1% |
| Total current assets | $21.08M | $13.93M | $10.21M | $36.02M | +51.4% |
| Total assets | $21.08M | $13.93M | $10.21M | $36.02M | +51.4% |
| Total current liabilities | $3.64M | $3.88M | $4.28M | $7.70M | -6.3% |
| Total liabilities | $4.23M | $4.62M | $17.96M | $7.70M | -8.4% |
| Retained earnings | -$163.70M | -$134.85M | -$110.26M | -$54.05M | -21.4% |
| Shareholder equity | $16.85M | $9.31M | -$7.75M | $28.32M | +81.0% |
| Working capital | $17.45M | $10.04M | $5.93M | $28.32M | +73.7% |
| Net tangible assets | $16.85M | $9.31M | -$7.75M | $28.32M | +81.0% |
| Shares issued | 27.20M | 14.14M | 10.52M | 8.16M | +92.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$28.85M | -$24.59M | -$56.20M | -$25.33M | -17.3% |
| Stock-based compensation | $1.80M | $3.84M | $4.63M | $9.15M | -53.1% |
| Change in working capital | $1.58M | $681.71K | -$228.60K | -$1.14M | +131.6% |
| Operating cash flow | -$25.62M | -$21.89M | -$39.97M | -$17.31M | -17.0% |
| Financing cash flow | $34.60M | $26.69M | $17.34M | $4.61K | +29.6% |
| Free cash flow | -$25.62M | -$21.89M | -$39.97M | -$17.31M | -17.0% |
| End cash position | $19.53M | $10.55M | $5.75M | $28.38M | +85.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — | — |
| Research & development | $16.72M | $8.75M | $6.29M | $5.16M | $5.01M | — | +91.1% |
| Selling, general & admin | $1.29M | $955.15K | $1.14M | $1.11M | $1.27M | — | +35.2% |
| Total operating expense | $18.01M | $9.71M | $7.43M | $6.27M | $6.28M | — | +85.6% |
| Operating income | -$18.01M | -$9.71M | -$7.43M | -$6.27M | -$6.28M | — | -85.6% |
| Net interest income | $137.80K | $167.74K | $152.32K | $191.40K | $187.61K | — | -17.8% |
| Pre-tax income | -$17.61M | -$9.83M | -$7.26M | -$6.22M | -$5.54M | — | -79.0% |
| Net income | -$17.61M | -$9.83M | -$7.26M | -$6.22M | -$5.54M | — | -79.0% |
| Net income to common | -$17.61M | -$9.83M | -$7.26M | -$6.22M | -$5.54M | — | -79.0% |
| Basic EPS | -0.63 | — | -0.37 | -0.32 | -0.32 | -0.43 | — |
| Diluted EPS | -0.63 | — | -0.37 | -0.32 | -0.32 | -0.43 | — |
| EBIT | -$18.01M | -$9.71M | -$7.43M | -$6.27M | -$6.28M | — | -85.6% |
| EBITDA | -$18.01M | -$9.71M | -$7.43M | -$6.27M | -$6.28M | — | -85.6% |
| Basic shares | 27.85M | — | 19.69M | 19.49M | 17.43M | 13.79M | — |
| Diluted shares | 27.85M | — | 19.69M | 19.49M | 17.43M | 13.79M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.22M | $19.53M | $15.29M | $17.13M | $22.24M | -27.2% |
| Cash & short-term investments | $14.22M | $19.53M | $15.29M | $17.13M | $22.24M | -27.2% |
| Total current assets | $16.24M | $21.08M | $17.19M | $21.45M | $26.74M | -22.9% |
| Total assets | $16.24M | $21.08M | $17.19M | $21.45M | $26.74M | -22.9% |
| Total current liabilities | $12.79M | $3.64M | $3.73M | $2.81M | $2.50M | +251.8% |
| Total liabilities | $13.12M | $4.23M | $4.03M | $3.12M | $2.68M | +210.1% |
| Retained earnings | -$181.31M | -$163.70M | -$153.87M | -$146.61M | -$140.39M | -10.8% |
| Shareholder equity | $3.13M | $16.85M | $13.16M | $18.33M | $24.05M | -81.4% |
| Working capital | $3.45M | $17.45M | $13.46M | $18.65M | $24.23M | -80.2% |
| Net tangible assets | $3.13M | $16.85M | $13.16M | $18.33M | $24.05M | -81.4% |
| Shares issued | 28.54M | 27.20M | 20.19M | 19.49M | 19.49M | +4.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$17.61M | -$9.83M | -$7.26M | -$6.22M | -$5.54M | -79.0% |
| Stock-based compensation | $182.82K | $356.52K | $444.65K | $496.62K | $499.89K | -48.7% |
| Change in working capital | $8.68M | $254.85K | $3.35M | $477.55K | -$2.50M | +3,305.9% |
| Operating cash flow | -$9.01M | -$8.93M | -$3.49M | -$5.11M | -$8.10M | -0.9% |
| Financing cash flow | $3.70M | $13.17M | $1.64M | $0 | $19.78M | -71.9% |
| Free cash flow | -$9.01M | -$8.93M | -$3.49M | -$5.11M | -$8.10M | -0.9% |
| End cash position | $14.22M | $19.53M | $15.29M | $17.13M | $22.24M | -27.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | 0.0% |
| Next quarter | — | — | $0 | 0.0% |
| Current year | — | — | $0 | 0.0% |
| Next year | — | — | $0 | 0.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders6.71%
Held by institutions27.91%
Institutions holding72
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.55
-0.44% from price
SMA 20
1.53
-1.01% from price
SMA 50
1.55
-2.22% from price
SMA 100
1.62
-4.41% from price
SMA 200
2.12
-28.50% from price
EMA 12
1.54
+0.24% from price
EMA 26
1.54
-0.06% from price
EMA 50
1.57
-1.83% from price
RSI (14)
47.1
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.04
2.77% of price
Realised vol 30D
49.2%
Annualised
Bollinger upper
1.64
20, 2σ
Bollinger lower
1.42
20, 2σ
50 / 200 cross
Death
1.55 vs 2.12
Trend bias
Below 200
-28.50%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.28
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
49.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-70.7%
Peak to trough
Max drawdown 5Y
-96.9%
Peak to trough
ATR 14
0.04
2.77% of price
Beta (reported)
1.24
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 18, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 8, 26 | Roth Capital | INITIATED | — | Buy |
| Apr 14, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 30, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 3, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 9, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 15, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Feb 10, 25 | D. Boral Capital | DOWNGRADE | Buy | Hold |
| Nov 11, 24 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Nov 11, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Oct 25, 24 | Maxim Group | UPGRADE | Hold | Buy |
| Aug 15, 24 | EF Hutton | MAINTAINED | Buy | Buy |
Headlines
FireFly bolsters funding for project development and ongoing resource growth with A$190m raising
GlobeNewswire · 6m ago
Economic study demonstrates scale, grade, long life, growth potential and robust financial returns
GlobeNewswire · 9m ago
Kyle Bachus of Bachus & Schanker Named 2026 Best Personal Injury Lawyer by Law Week Colorado
ACCESS Newswire · 13m ago
Trump makes final pitch for Sen. Darline Graham before South Carolina runoff
USA TODAY · 16m ago
NewPeak Metals to showcase Las Opeñas drilling results in investor webinar
Proactive · 18m ago
South Korea's SK Hynix union members reject wage agreement in vote
Reuters · 20m ago
Federer looks forward to brief return to Arthur Ashe stadium
AFP · 22m ago
Gold Gains; Potential to Rise to $5,000 Intact
The Wall Street Journal · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.